HOME > ARCHIVE
ARCHIVE
- R&D NEWS IN BRIEF
July 25, 2005
- Rozerem Could Reach US Market in Sept. at Earliest: Takeda
July 25, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 25, 2005
- Janssen Pharm. to Revise Marketing System
July 25, 2005
- Overseas Sales Account for 60% of Sales: Toshiba Medical Systems
July 25, 2005
- Toyobo to Expand Life Science Business
July 25, 2005
- Sakura Group Companies to Be Reorganized
July 25, 2005
- BUSINESS NEWS IN BRIEF
July 25, 2005
- MEDICAL DEVICE NEWS IN BRIEF
July 25, 2005
- NEW PRODUCTS
July 25, 2005
- Inhaled Steroids Reduce Medical Costs for Asthma Patients: GSK
July 25, 2005
- JGPMA to Beef Up Preparations for Formal Membership in IGPA
July 25, 2005
- 7th ICAAP Reviews Anti-AIDS Measures
July 25, 2005
- JRCS to Test Joint Purchasing
July 25, 2005
- Generic Drug Request Card Welcomed: JSGM
July 25, 2005
- Taisho Pharm. Ind. Opens New R&D Facility in Koga
July 25, 2005
- NEW PRODUCTS
July 18, 2005
- Otsuka: Consolidated Sales Rise 39.9% to \683,804 Mil.
July 18, 2005
- Nippon Kayaku: Pharma Sales Fall 3.6% to \39,660 Mil.
July 18, 2005
- Astellas Has YM155 to Treat Prostate Cancer in PII
July 18, 2005
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
